<HTML>
<HEAD>
<TITLE>Advanced Medical Optics Inc  Form S-8</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<P align="center"><FONT size="2"><B>As filed with the Securities and Exchange Commission on June&nbsp;21, 2002</B></FONT>

<DIV align="right"><FONT size="2"><B>Registration No.&nbsp;333-____</B></FONT></DIV>

<HR size="4" noshade color="#000000" style="margin-top: -5px">
<HR size="1" noshade color="#000000" style="margin-top: -10px">

<DIV align="center"><FONT size="3"><B>SECURITIES AND EXCHANGE COMMISSION</B></FONT><BR>
<FONT size="2"><B>Washington, D.C. 20549</B></FONT></DIV>

<HR width="26%" align="center" size="1" noshade>

<DIV align="center"><FONT size="3"><B>FORM S-8<BR>
REGISTRATION STATEMENT<BR>
UNDER<BR>
THE SECURITIES ACT OF 1933</B></FONT></DIV>

<HR width="26%" align="center" size="1" noshade>


<P align="center"><FONT size="3"><B>ADVANCED MEDICAL OPTICS, INC.</B></FONT><BR>
<FONT size="1">(Exact name of Registrant as specified in its charter)</FONT>

<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
        <TD width="48%">&nbsp;</TD>
        <TD width="4%">&nbsp;</TD>
        <TD width="48%">&nbsp;</TD>
</TR>
<TR valign="bottom">
        <TD align="center" valign="top"><FONT size="2"><B>Delaware</B></FONT><BR>
<FONT size="1">(State or other jurisdiction<BR>
of incorporation or organization)</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center" valign="top"><FONT size="2">
<B>33-098682</B></FONT><BR>
<FONT size="1">(I.R.S. Employer<BR>
Identification No.)</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2"><B>2525 Dupont Drive<BR>
Irvine, California 92612<BR>
(714)&nbsp;246-4500</B></FONT><BR>
<FONT size="1">(Address of principal executive offices, including zip code, and telephone number)</FONT>

<HR width="26%" align="center" size="1" noshade>

<DIV align="center"><FONT size="2"><B>ADVANCED MEDICAL OPTICS, INC. 401(K) PLAN<BR>
ADVANCED MEDICAL OPTICS, INC. 2002 INCENTIVE COMPENSATION PLAN<BR>
ADVANCED MEDICAL OPTICS, INC. 2002 EMPLOYEE STOCK PURCHASE PLAN<BR>
ADVANCED MEDICAL OPTICS, INC. 2002 INTERNATIONAL STOCK PURCHASE PLAN<BR>
ADVANCED MEDICAL OPTICS, INC. EXECUTIVE DEFERRED COMPENSATION PLAN<BR>
AMO IRISH SAVINGS RELATED SHARE OPTION SCHEME<BR>
AMO (IRELAND)&nbsp;SHARE PARTICIPATION SCHEME</B></FONT><BR>
<FONT size="1">(Full title of the plans)</FONT></DIV>

<HR width="26%" align="center" size="1" noshade>

<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
        <TD width="48%">&nbsp;</TD>
        <TD width="4%">&nbsp;</TD>
        <TD width="48%">&nbsp;</TD>
</TR>
<TR valign="bottom">
        <TD align="center" valign="top"><FONT size="2"><B>JAMES V. MAZZO</B></FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center" valign="top"><FONT size="2">
Copies to:</FONT></TD>
</TR>

<TR valign="bottom">
        <TD align="center" valign="top"><FONT size="2"><B>President and<BR>
Chief Executive Officer<BR>
Advanced Medical Optics, Inc.<BR>
2525 Dupont Drive<BR>
Irvine, California 92612<BR>
(714)&nbsp;246-4500</B></FONT><BR>
<FONT size="1">(Name, address, including zip code, and telephone number,<BR>
including area code, of agent for service)</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center" valign="top"><FONT size="2">
<B>CARY K. HYDEN<BR>
JONN R. BEESON<BR>
Latham &#038; Watkins<BR>
650 Town Center, 20th floor<BR>
Costa Mesa, California 92626<BR>
(714)&nbsp;540-1235</B></FONT></TD>
</TR>
</TABLE>
</CENTER>
<HR width="26%" align="center" size="1" noshade>

<DIV align="center"><FONT size="2"><B>CALCULATION OF REGISTRATION FEE</B></FONT></DIV>

<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
        <TD width="28%">&nbsp;</TD>
        <TD width="3%">&nbsp;</TD>
        <TD width="7%">&nbsp;</TD>
        <TD width="1%">&nbsp;</TD>
        <TD width="7%">&nbsp;</TD>
        <TD width="3%">&nbsp;</TD>
        <TD width="7%">&nbsp;</TD>
        <TD width="1%">&nbsp;</TD>
        <TD width="7%">&nbsp;</TD>
        <TD width="3%">&nbsp;</TD>
        <TD width="7%">&nbsp;</TD>
        <TD width="1%">&nbsp;</TD>
        <TD width="7%">&nbsp;</TD>
        <TD width="3%">&nbsp;</TD>
        <TD width="7%">&nbsp;</TD>
        <TD width="1%">&nbsp;</TD>
        <TD width="7%">&nbsp;</TD>
</TR>
<TR valign="bottom">
        <TD colspan="17"><FONT size="1"><HR noshade size="4"></FONT></TD>
</TR>
<TR valign="bottom">
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1">Amount</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1">Proposed Maximum</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1">Proposed Maximum</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1">Amount of</FONT></TD>
</TR>
<TR valign="bottom">
        <TD nowrap align="center"><FONT size="1">Title of Securities</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1">to be</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1">Offering Price</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1">Aggregate Offering</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1">Registration</FONT></TD>
</TR>
<TR valign="bottom">
        <TD nowrap align="center"><FONT size="1">to be Registered</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1">Registered</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1">Per Share</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1">Price</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1">Fee</FONT></TD>
</TR>
<TR valign="bottom">
        <TD colspan="17"><FONT size="1"><HR noshade size="1"></FONT></TD>
</TR>
<TR valign="bottom">
        <TD nowrap><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">Common Stock, par value $0.01 per share</FONT></DIV></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD nowrap align="right"><FONT size="2">&nbsp;</FONT></TD>
        <TD align="right"><FONT size="2">10,300,000</FONT></TD>
        <TD nowrap><FONT size="2">(1)(2)</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD nowrap align="right"><FONT size="2">$</FONT></TD>
        <TD align="right"><FONT size="2">11.45</FONT></TD>
        <TD nowrap><FONT size="2">(3)</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD nowrap align="right"><FONT size="2">$</FONT></TD>
        <TD align="right"><FONT size="2">117,935,000</FONT></TD>
        <TD nowrap><FONT size="2">(3)</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="right"><FONT size="2">$</FONT></TD>
        <TD align="right"><FONT size="2">10,851</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
        <TD><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">Deferred Compensation Obligations</FONT></DIV></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD nowrap align="right"><FONT size="2">$</FONT></TD>
        <TD align="right"><FONT size="2">3,000,000</FONT></TD>
        <TD nowrap><FONT size="2">(4)</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD nowrap align="right"><FONT size="2">&nbsp;</FONT></TD>
        <TD align="right"><FONT size="2">100</FONT></TD>
        <TD nowrap><FONT size="2">%</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="right"><FONT size="2">$</FONT></TD>
        <TD align="right"><FONT size="2">3,000,000</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="right"><FONT size="2">$</FONT></TD>
        <TD align="right"><FONT size="2">276</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="bottom">
        <TD colspan="17"><FONT size="1"><HR noshade size="4"></FONT></TD>
</TR>
</TABLE>
</CENTER>
<P>
<HR size="1" width="18%" align="left" noshade>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR valign="top">
      <TD width="1%" align="left" nowrap><FONT size="2">(1)</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="96%"><FONT size="2">Pursuant to Rule&nbsp;416(a) under the Securities Act of 1933, as amended,
this Registration Statement shall also automatically cover any
additional shares of common stock, par value $0.01 per share (the
&#147;Common Stock&#148;), that become issuable under the plans being registered
pursuant to this Registration Statement by reason of any stock dividend,
stock split or other similar transaction.</FONT></TD>
</TR>
<TR><TD><TR><TD><TR><TD><TR><TD>
<TR valign="top">
      <TD width="1%" align="left" nowrap><FONT size="2">(2)</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="96%"><FONT size="2">Represents 400,000 shares authorized for issuance under the Advanced
Medical Optics, Inc. 401(k) Plan, 6,700,000 shares authorized for
issuance under the Advanced Medical Optics, Inc. 2002 Incentive
Compensation Plan, 2,900,000 shares authorized for issuance under the
Advance Medical Optics, Inc. 2002 Employee Stock Purchase Plan and 2002
International Stock Purchase Plan, 150,000 shares reserved for issuance under the AMO Irish Savings Related Share Option Scheme and
150,000 shares reserved for issuance under the AMO (Ireland) Share
Participation Scheme. In addition, pursuant to Rule&nbsp;416(c) under the
Securities Act of 1933, as amended, this Registration Statement also
covers an indeterminate amount of interests to be offered or sold
pursuant to the Advanced Medical Optics, Inc. 401(k) Plan described
herein.</FONT></TD>
</TR>
<TR><TD><TR><TD><TR><TD><TR><TD>
<TR valign="top">
      <TD width="1%" align="left" nowrap><FONT size="2">(3)</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="96%"><FONT size="2">Estimated solely for the purpose of calculating the registration fee
pursuant to Rule&nbsp;457(h) under the Securities Act of 1933, as amended,
and is based on the average of the high and low sales price of the
Company&#146;s Common Stock on June&nbsp;20, 2002, trading on a &#147;when issued&#148;
basis.</FONT></TD>
</TR>
</TABLE>
<P align="center"><FONT size="2">1
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>



<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR valign="top">
      <TD width="1%" align="left" nowrap><FONT size="2">(4)</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="96%"><FONT size="2">This Registration Statement is also filed for up to $3,000,000 in
deferred compensation obligations of the Company pursuant to the
Advanced Medical Optics, Inc. Executive Deferred Compensation Plan,
reflecting unsecured obligations of the Company to pay, in the future,
deferred compensation in accordance with the terms of such plan.</FONT></TD>
</TR>
</TABLE>

<P align="center"><FONT size="2"><B>Proposed sale to take place from time to time after the effective date of the Registration Statement.</B></FONT>

<HR size="1" noshade color="#000000" style="margin-top: -2px">
<HR size="4" noshade color="#000000" style="margin-top: -10px">




<P align="center"><FONT size="2"><B>Total Pages 241<BR>
Exhibit&nbsp;Index on Page 9</B></FONT>

<P align="center"><FONT size="2">2
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>


<!-- TOC -->
<A name="toc"><DIV align="CENTER" style="page-break-before:always"><U><B>TABLE OF CONTENTS</B></U></DIV></A>

<P><CENTER>
<TABLE border="0" width="90%" cellpadding="0" cellspacing="0">
<TR>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="76%"></TD>
</TR>
<TR><TD colspan="9"><A HREF="#000">PART I</A></TD></TR>
<TR><TD colspan="9"><A HREF="#001">PART II</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#002">Item&nbsp;3. Incorporation of Documents by Reference.</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#003">Item&nbsp;4. Description of Securities.</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#004">Item&nbsp;5. Interests of Named Experts and Counsel.</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#005">Item&nbsp;6. Indemnification of Directors and Officers.</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#006">Item&nbsp;7. Exemption from Registration Claimed.</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#007">Item&nbsp;8. Exhibits.</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#008">Item&nbsp;9. Undertakings.</A></TD></TR>
<TR><TD colspan="9"><A HREF="#009">SIGNATURES</A></TD></TR>
<TR><TD colspan="9"><A HREF="#010">EXHIBIT INDEX</A></TD></TR>
<TR><TD colspan="9"><A HREF="a82548exv5w1.txt">EXHIBIT 5.1</A></TD></TR>
<TR><TD colspan="9"><A HREF="a82548exv10w1.txt">EXHIBIT 10.1</A></TD></TR>
<TR><TD colspan="9"><A HREF="a82548exv10w2.txt">EXHIBIT 10.2</A></TD></TR>
<TR><TD colspan="9"><A HREF="a82548exv10w3.txt">EXHIBIT 10.3</A></TD></TR>
<TR><TD colspan="9"><A HREF="a82548exv10w4.txt">EXHIBIT 10.4</A></TD></TR>
<TR><TD colspan="9"><A HREF="a82548exv10w5.txt">EXHIBIT 10.5</A></TD></TR>
<TR><TD colspan="9"><A HREF="a82548exv23w1.txt">Exhibit 23.1</A></TD></TR>
</TABLE>
</CENTER>
<!-- /TOC -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>




<!-- link1 "PART I" -->
<DIV align="left"><A NAME="000"></A></DIV>
<P align="center"><FONT size="2"><B>PART I</B></FONT>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The information called for in Part I of Form&nbsp;S-8 is not being prepared
with or included in this Form&nbsp;S-8 (by incorporation by reference or otherwise)
in accordance with the rules and regulations of the Securities and Exchange
Commission (&#147;SEC&#148;).
</FONT>
<!-- link1 "PART II" -->
<DIV align="left"><A NAME="001"></A></DIV>
<P align="center"><FONT size="2"><B>PART II</B></FONT>

<!-- link2 "Item&nbsp;3. Incorporation of Documents by Reference." -->
<DIV align="left"><A NAME="002"></A></DIV>
<P align="left"><FONT size="2"><B>Item&nbsp;3. Incorporation of Documents by Reference.</B></FONT>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following documents previously filed with the SEC by us are hereby
incorporated by reference in this Registration Statement:
</FONT>
<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR valign="top">
   <TD width="1%" nowrap><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
   <TD width="1%" align="right" nowrap><FONT size="2">(a)</FONT></TD>
   <TD width="1%" nowrap><FONT size="2">&nbsp;&nbsp;</FONT></TD>
   <TD width="97%"><FONT size="2">Form&nbsp;10 filed with the SEC on March&nbsp;1, 2002, pursuant to the
Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;),
including any subsequent amendment or report filed for the purpose
of amending such description, which Form&nbsp;10 includes the description
of our Common Stock.</FONT></TD>
</TR>
</TABLE>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All documents filed by us pursuant to Section&nbsp;13(a), 13(c), 14 and 15(d)
of the Exchange Act subsequent to the date this Registration Statement is filed
with the SEC and prior to the filing of a post-effective amendment that
indicates that all securities offered have been sold or that deregisters all
securities then remaining unsold shall be deemed to be incorporated by
reference in this Registration Statement and to be a part of it from the
respective dates of filing of such documents. Any statement contained in a
document incorporated or deemed to be incorporated by reference herein shall be
deemed to be modified or superseded for purposes of this Registration Statement
to the extent that a statement contained herein or in any other subsequently
filed document that also is or is deemed to be incorporated by reference herein
modifies or supersedes such statement. Any such statement so modified or
superseded shall not be deemed, except as so modified or superseded, to
constitute a part of this Registration Statement.
</FONT>
<!-- link2 "Item&nbsp;4. Description of Securities." -->
<DIV align="left"><A NAME="003"></A></DIV>
<P align="left"><FONT size="2"><B>Item&nbsp;4. Description of Securities.</B></FONT>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following description of the deferred compensation obligations (the
&#147;Obligations&#148;) of the Company under the Advanced Medical Optics, Inc. Executive
Deferred Compensation Plan (the &#147;EDCP&#148;) is qualified by reference to the EDCP.
Capitalized terms used in this Item&nbsp;4 and not otherwise defined in this
Registration Statement shall have the respective meanings attributed to such
terms in the EDCP.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The $3,000,000 of Obligations being registered under this Registration
Statement are to be offered to a select group of management and highly
compensated employees of the Company who meet certain eligibility requirements
and who have completed and submitted to the Company a written agreement
electing to participate in the EDCP (a &#147;Participation Agreement&#148;). The
Obligations are general unsecured and unfunded obligations of the Company to
pay deferred compensation in the future in accordance with the terms of the
EDCP.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The amount of compensation deferred by each participant in the EDCP is
determined in accordance with the EDCP based upon elections by each
participant. To participate in the EDCP, during the calendar year, a
participant must defer a minimum of $5,000 (or other such minimum amount as may
be designated by the committee that administers the EDCP (the &#147;Committee&#148;))
from either base salary or bonuses or a combination of base salary and bonuses,
and may elect to defer up to a maximum of 100% of such participant&#146;s base
salary and bonuses earned during the calendar year (&#147;Deferral Amount&#148;) by
completing and submitting to the Company a &#147;Deferral Election Form.&#148;
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Obligations will consist of an amount equal to each participant&#146;s
&#147;Deferral Account&#148; under the EDCP, which includes (i)&nbsp;the sum of the
participant&#146;s Deferral Amounts, plus (ii)&nbsp;amounts credited to the participant&#146;s
Deferral Account based on the participant&#146;s selection from measurement fund
alternatives in accordance with and subject to the rules and procedures
established from time to time by the Committee, plus (iii)&nbsp;any Profit Sharing
Restoration Credits which have been added to the participant&#146;s Deferral
Account; plus (iv)&nbsp;any Matching Contribution Restoration Credits which have
been added to the participant&#146;s Deferral Account; plus (v)&nbsp;any Discretionary
Credits (amounts determined in the discretion of the Committee, not to exceed
$200,000 for any participant in any Plan Year) which have been added to the
participant&#146;s Deferral Account; less (vi)&nbsp;all distributions made to the
participant or his or her beneficiary pursuant to the EDCP that relate to the
participant&#146;s Deferral Account. For these purposes, (i)&nbsp;Profit Sharing
Restoration Credits equal the excess of the participant&#146;s &#147;Profit Sharing
Contribution&#148; (as defined in the Advanced Medical Optics, Inc. 401(k) Plan) for
the Plan Year under the
</FONT>
<P align="center"><FONT size="2">3
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<P><FONT size="2">Advanced Medical Optics, Inc. 401(k) Plan, had the participant&#146;s
&#147;Compensation&#148; (as defined in the Advanced Medical Optics, Inc. 401(k) Plan)
been calculated without deducting annual deferrals under the EDCP and had such
Profit Sharing Contribution been calculated without regard to Internal Revenue
Code limitations, over the participant&#146;s actual Profit Sharing Contribution for
the Plan Year under the Advanced Medical Optics, Inc. 401(k) Plan and (ii)
Matching Contribution Restoration Credits equal the excess of the participant&#146;s
&#147;Matching Contributions&#148; (as defined in the Advanced Medical Optics, Inc.
401(k) Plan) for the Plan Year under the Advanced Medical Optics, Inc. 401(k)
Plan, determined based on the participant&#146;s &#147;Matched
Deposits&#148; (as defined in the Advanced Medical Optics, Inc.
401(k) Plan) and had the participant&#146;s &#147;Compensation&#148; (as defined in the Advanced Medical
Optics, Inc. 401(k) Plan) been calculated without deducting annual deferrals
under the EDCP and had such Matching Contributions been calculated without
regard to Internal Revenue Code limitations, over the participant&#146;s actual
Matching Contributions for the Plan Year under the Advanced Medical Optics,
Inc. 401(k) Plan. A Matching Contribution Restoration Credit will be
credited to a participant&#146;s Deferral Account only if he or she
has contributed the maximum &#147;Before Tax Deposits&#148; (as
defined in the Advanced Medical Optics, Inc. 401(k) Plan) permitted
under the terms of the Advanced Medical Optics, Inc. 401(k) Plan for
a Plan Year.
</FONT>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A participant may elect in his or her Participation Agreement to receive
distributions from his or her Deferral Account in one of several manners,
including lump sum or installment payments. The distribution choices provided
to a participant may differ depending on the circumstances under which that
participant terminates employment with the Company, for instance by retirement,
death or disability. The participant also may be eligible to receive
distributions or make unscheduled withdrawals from his or her Deferral Account
while still employed with the Company.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;An irrevocable rabbi trust established contemporaneously with the
establishment of the EDCP is to pay the Obligations. All amounts of base salary
or bonuses that are deferred under the EDCP shall be contributed to the trust.
The EDCP is administered by the Committee, which is appointed by the Corporate
Benefits Committee of the Company, and which has the power to make, amend,
interpret and enforce all appropriate rules and regulations for the
administration of the EDCP, to construe and resolve all questions arising under
the EDCP, and otherwise to carry out the terms of the EDCP. The Company, by
action of the Board, may terminate the EDCP at any time and may amend the EDCP
from time to time; provided, however, that no such amendment or termination
shall be effective, without the participant&#146;s consent, to the extent it reduces
or eliminates (except to the extent that amounts are distributed under the
EDCP) the value of a participant&#146;s Deferral Account balance in existence as of
such amendment or termination.
</FONT>
<!-- link2 "Item&nbsp;5. Interests of Named Experts and Counsel." -->
<DIV align="left"><A NAME="004"></A></DIV>
<P align="left"><FONT size="2"><B>Item&nbsp;5. Interests of Named Experts and Counsel.</B></FONT>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The combined balance sheets of the optical medical device business of
Allergan, Inc. (Advanced Medical Optics, Inc.) as of December&nbsp;31, 2001 and
2000, and the related combined statements of earnings, equity and comprehensive
income, and cash flows for each of the years in the three-year period ended
December&nbsp;31, 2001, and the financial statement schedule contained in the Form
10, as amended, of Advanced Medical Optics, Inc. have been incorporated by
reference herein in reliance upon the report of KPMG LLP, independent certified
public accountants, incorporated by reference herein, and upon the authority of
said firm as experts in accounting and auditing.
</FONT>
<!-- link2 "Item&nbsp;6. Indemnification of Directors and Officers." -->
<DIV align="left"><A NAME="005"></A></DIV>
<P align="left"><FONT size="2"><B>Item&nbsp;6. Indemnification of Directors and Officers.</B></FONT>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company is incorporated under the laws of the State of Delaware.
Reference is made to Section&nbsp;102(b)(7) of the Delaware General Corporation Law,
or DGCL, which enables a corporation in its original certificate of
incorporation or an amendment thereto to eliminate or limit the personal
liability of a director for violations of the director&#146;s fiduciary duty, except
(1)&nbsp;for any breach of the director&#146;s duty of loyalty to the corporation or its
stockholders, (2)&nbsp;for acts or omissions not in good faith or which involve
intentional misconduct or a knowing violation of law, (3)&nbsp;pursuant to Section
174 of the DGCL, which provides for liability of directors for unlawful
payments of dividends of unlawful stock purchase or redemptions, or (4)&nbsp;for any
transaction from which a director derived an improper personal benefit.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Reference is also made to Section&nbsp;145 of the DGCL, which provides that a
corporation may indemnify any person, including an officer or director, who is,
or is threatened to be made, party to any threatened, pending or completed
legal action, suit or proceeding, whether civil, criminal, administrative or
investigative, other than an action by or in the right of such corporation, by
reason of the fact that such person was an officer, director, employee or agent
of such corporation or is or was serving at the request of such corporation as
a director, officer, employee or agent of another corporation or enterprise.
The indemnity may include expenses (including attorneys&#146; fees), judgments,
fines and amounts paid in settlement actually and reasonably incurred by such
person in connection with such action, suit or proceeding, provided such
officer, director, employee or agent acted in good faith and in a manner he
reasonably believed to be in, or not opposed to, the corporation&#146;s best
interest and, for criminal proceedings, had no reasonable cause to believe that
his conduct was unlawful. A Delaware corporation may
</FONT>
<P align="center"><FONT size="2">4
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<P><FONT size="2">indemnify any officer or director in an action by or in the right of the
corporation under the same conditions, except that no indemnification is
permitted without judicial approval if the officer or director is adjudged to
be liable to the corporation. Where an officer or director is successful on
the merits or otherwise in the defense of any action referred to above, the
corporation must indemnify him against the expenses that such officer or
director actually and reasonably incurred.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our amended and restated certificate of incorporation provides for
indemnification of the officers and directors to the full extent permitted by
applicable law.
</FONT>
<!-- link2 "Item&nbsp;7. Exemption from Registration Claimed." -->
<DIV align="left"><A NAME="006"></A></DIV>
<P align="left"><FONT size="2"><B>Item&nbsp;7. Exemption from Registration Claimed.</B></FONT>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Not Applicable.
</FONT>
<!-- link2 "Item&nbsp;8. Exhibits." -->
<DIV align="left"><A NAME="007"></A></DIV>
<P align="left"><FONT size="2"><B>Item&nbsp;8. Exhibits.</B></FONT>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A list of exhibits filed with this Registration Statement is set forth in
the Exhibit&nbsp;Index and is incorporated herein by reference.
</FONT>
<!-- link2 "Item&nbsp;9. Undertakings." -->
<DIV align="left"><A NAME="008"></A></DIV>
<P align="left"><FONT size="2"><B>Item&nbsp;9. Undertakings.</B></FONT>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp; The undersigned registrant hereby undertakes:
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp; To file, during any period in which offers or sales are being made, a
post-effective amendment to this Registration Statement:
</FONT>
<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR valign="top">
   <TD width="8%" nowrap><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
   <TD width="1%" align="right" nowrap><FONT size="2">(i)</FONT></TD>
   <TD width="1%" nowrap><FONT size="2">&nbsp;&nbsp;</FONT></TD>
   <TD width="90%"><FONT size="2">To include any prospectus required by Section
10(a)(3) of the Securities Act of 1933
(the &#147;Securities Act&#148;);</FONT></TD>
</TR>
<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
   <TD width="1%" nowrap><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
   <TD width="1%" align="right" nowrap><FONT size="2">(ii)</FONT></TD>
   <TD width="1%" nowrap><FONT size="2">&nbsp;&nbsp;</FONT></TD>
   <TD width="97%"><FONT size="2">To reflect in the prospectus any facts or events
arising after the effective date of this Registration
Statement (or the most recent post-effective amendment
thereof) which, individually or in the aggregate, represent a
fundamental change in the information set forth in this
Registration Statement. Notwithstanding the foregoing, any
increase or decrease in volume of securities offered (if the
total dollar value of securities offered would not exceed that
which was registered) and any deviation from the low or high
end of the estimated maximum offering range may be reflected
in the form of prospectus filed with the SEC pursuant to Rule
424(b) if, in the aggregate, the changes in volume and price
represent no more than 20&nbsp;percent change in the maximum
aggregate offering price set forth in the &#147;Calculation of
Registration Fee&#148; table in the effective Registration
Statement; and</FONT></TD>
</TR>
<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
   <TD width="1%" nowrap><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
   <TD width="1%" align="right" nowrap><FONT size="2">(iii)</FONT></TD>
   <TD width="1%" nowrap><FONT size="2">&nbsp;&nbsp;</FONT></TD>
   <TD width="97%"><FONT size="2">To include any material information with respect
to the plan of distribution not previously disclosed in this
Registration Statement or any material change to such
information in this Registration Statement;</FONT></TD>
</TR>
</TABLE>
<P><FONT size="2"><I>provided, however</I>, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the
information required to be included in a post-effective amendment by those
paragraphs is contained in periodic reports filed with or furnished to the SEC
by the Company pursuant to Section&nbsp;13 or Section&nbsp;15(d) of the Exchange Act that
are incorporated by reference in this Registration Statement.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp; That, for the purpose of determining any liability under the
Securities Act, each such post-effective amendment shall be deemed to be a new
Registration Statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial <I>bona
fide </I>offering thereof.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp; To remove from registration by means of a post-effective amendment any
of the securities being registered which remain unsold at the termination of
the offering.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp; The undersigned registrant hereby undertakes that, for purposes of
determining any liability under the Securities Act, each filing of an annual
report of the Company pursuant to Section&nbsp;13(a) or Section&nbsp;15(d) of the
Exchange Act (and, where applicable, each filing of an employee benefit plan&#146;s
annual report pursuant to Section&nbsp;15(d) of the Exchange Act) that is
incorporated by reference in this Registration Statement shall be deemed to be
a
</FONT>
<P align="center"><FONT size="2">5
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<P><FONT size="2">new Registration Statement relating to the securities offered therein, and
the offering of such securities at that time shall be deemed to be the initial
<I>bona fide </I>offering thereof.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp; Insofar as indemnification for liabilities arising under the
Securities Act may be permitted to directors, officers and controlling persons
of the Company pursuant to existing provisions, or otherwise, the Company has
been advised that in the opinion of the SEC such indemnification is against
public policy as expressed in the Securities Act and is, therefore,
unenforceable. In the event that a claim for indemnification against such
liabilities (other than the payment by the Company of expenses incurred or
paid by a director, officer or controlling person of the Company in the
successful defense of any action, suit or proceeding) is asserted by such
director, officer or controlling person in connection with the securities being
registered, the Company will, unless in the opinion of its counsel the matter
has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against public
policy as expressed in the Securities Act and will be governed by the final
adjudication of such issue.
</FONT>
<P align="center"><FONT size="2">6
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
<!-- link1 "SIGNATURES" -->
<DIV align="left"><A NAME="009"></A></DIV>
<P align="center"><FONT size="2"><B>SIGNATURES</B></FONT>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act, the Company certifies
that it has reasonable grounds to believe that it meets all of the requirements
for filing on Form&nbsp;S-8 and has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly authorized, in the High
Wycombe, England, on June&nbsp;19, 2002.
</FONT>
<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR valign="top">
        <TD width="30%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="70%"><FONT size="2">ADVANCED MEDICAL OPTICS, INC.</FONT></TD>
</TR>
</TABLE>
<P>&nbsp;
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR valign="top">
        <TD width="50%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="4%"><FONT size="2">By:</FONT></TD>
        <TD width="46%"><FONT size="2">/s/ JAMES V. MAZZO<BR>
<HR noshade size="1">
James V. Mazzo<BR>
President and Chief Executive Officer</FONT></TD>
</TR>
</TABLE>
<P align="center"><FONT size="2"><B>POWER OF ATTORNEY</B></FONT>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act, this Registration
Statement has been signed by the following persons in the capacities on June
19, 2002. Each person whose signature appears below authorizes James V. Mazzo
and Aimee S. Weisner, and either of them, with full power of substitution and
resubstitution, his true and lawful attorneys-in-fact, for him in any and all
capacities, to sign any amendments (including post-effective amendments or
supplements) to this Registration Statement and to file the same, with exhibits
thereto, and other documents in connection therewith, with the SEC.
</FONT>
<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="90%">
<TR valign="bottom">
        <TD width="43%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="4%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="43%">&nbsp;</TD>
</TR>
<TR valign="bottom">
        <TD nowrap align="left"><FONT size="1">Signature</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="left"><FONT size="1">Title</FONT></TD>
</TR>
<TR valign="bottom">
        <TD nowrap align="center"><HR size="1" noshade></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center"><HR size="1" noshade></TD>
</TR>
<TR>
        <TD><FONT size="1">&nbsp;</FONT></TD>
</TR>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">/s/ JAMES V. MAZZO</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">President and Chief Executive Officer (Principal</FONT></TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><HR size="1" noshade></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">Executive Officer)</FONT></TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">James V. Mazzo</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR>
        <TD><FONT size="1">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">/s/ WILLIAM R. GRANT</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><HR size="1" noshade></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">Chairman of the Board</FONT></TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">William R. Grant</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR>
        <TD><FONT size="1">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">/s/ DAVID E.I. PYOTT</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><HR size="1" noshade></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">Director</FONT></TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">David E. I. Pyott</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR>
        <TD><FONT size="1">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">/s/ RICHARD A. MEIER</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><HR size="1" noshade></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>

<TD align="left" valign="top"><FONT size="2">Corporate&nbsp;Vice&nbsp;President&nbsp;and&nbsp;Chief&nbsp;Financial&nbsp;Officer</FONT></TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">Richard A. Meier</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR>
        <TD><FONT size="1">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">/s/ ROBERT F. GALLAGHER</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><HR size="1" noshade></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">Vice President and Controller</FONT></TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">Robert F. Gallagher</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2">7
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
<P align="center"><FONT size="2"><B>SIGNATURE</B></FONT>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>The Plan</I>. Pursuant to the requirements of the Securities Act, the
Advanced Medical Optics, Inc. 401(k) Plan has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Irvine, State of California, on June&nbsp;20, 2002.
</FONT>
<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR valign="top">
        <TD width="50%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="50%"><FONT size="2">ADVANCED MEDICAL OPTICS, INC. 401(K) PLAN</FONT></TD>
</TR>
</TABLE>
<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR valign="top">
        <TD width="50%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="4%"><FONT size="2">By:</FONT></TD>
        <TD width="46%"><FONT size="2">Advanced Medical Optics, Inc.<BR>
Corporate Benefits Committee<BR>
Plan Administrator</FONT></TD>
</TR>
</TABLE>
<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR valign="top">
        <TD width="50%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="4%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="46%"><FONT size="2">/s/ RICHARD A. MEIER<BR>
<HR noshade size="1">
Richard A. Meier</FONT></TD>
</TR>
</TABLE>
<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR valign="top">
        <TD width="50%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="4%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="46%"><FONT size="2">/s/ AIMEE S. WEISNER<BR>
<HR noshade size="1">
Aimee S. Weisner</FONT></TD>
</TR>
</TABLE>
<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR valign="top">
        <TD width="50%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="4%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="46%"><FONT size="2">/s/ C. RUSSELL TRENARY III<BR>
<HR noshade size="1">
C. Russell Trenary III</FONT></TD>
</TR>
</TABLE>
<P align="center"><FONT size="2">8
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<!-- link1 "EXHIBIT INDEX" -->
<DIV align="left"><A NAME="010"></A></DIV>

<P align="center"><FONT size="2"><B>EXHIBIT INDEX</B></FONT>

<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="90%">
<TR valign="bottom">
        <TD width="6%">&nbsp;</TD>
        <TD width="3%">&nbsp;</TD>
        <TD width="85%">&nbsp;</TD>
        <TD width="3%">&nbsp;</TD>
        <TD width="3%">&nbsp;</TD>
</TR>
<TR valign="bottom">
        <TD nowrap align="center"><FONT size="1">EXHIBIT</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center"><FONT size="1">PAGE</FONT></TD>
</TR>
<TR valign="bottom">
        <TD nowrap align="center"><HR size="1" noshade></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center"><HR size="1" noshade></TD>
</TR>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">4.1</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Specimen Common Stock certificates
</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center" valign="top"><FONT size="2">*</FONT></TD>
</TR>
<TR>
        <TD><FONT size="1">&nbsp;</FONT></TD>
</TR>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">4.2</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Form of Rights Agreements and attached Form of Right Certificate and attached
Form of Certificate of Designations of Series&nbsp;A Participating Cumulative
Preferred Stock.
</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center" valign="top"><FONT size="2">**</FONT></TD>
</TR>
<TR>
        <TD><FONT size="1">&nbsp;</FONT></TD>
</TR>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">5.1</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Opinion of Latham &#038; Watkins</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR>
        <TD><FONT size="1">&nbsp;</FONT></TD>
</TR>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">10.1</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Advanced Medical Optics, Inc. 401(k) Plan</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR>
        <TD><FONT size="1">&nbsp;</FONT></TD>
</TR>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">10.2</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Advanced Medical Optics, Inc. 2002 Incentive Compensation Plan</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR>
        <TD><FONT size="1">&nbsp;</FONT></TD>
</TR>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">10.3</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Advanced Medical Optics, Inc. 2002 Employee Stock Purchase Plan</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR>
        <TD><FONT size="1">&nbsp;</FONT></TD>
</TR>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">10.4</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Advanced Medical Optics, Inc. International Stock Purchase Plan</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR>
        <TD><FONT size="1">&nbsp;</FONT></TD>
</TR>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">10.5</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Advanced Medical Optics, Inc. Executive Deferred Compensation Plan</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR>
        <TD><FONT size="1">&nbsp;</FONT></TD>
</TR>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">23.1</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Consent of KPMG LLP, Independent Auditors.</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR>
        <TD><FONT size="1">&nbsp;</FONT></TD>
</TR>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">23.2</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Consent of Latham &#038; Watkins (included in Exhibit&nbsp;5.1).</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR>
        <TD><FONT size="1">&nbsp;</FONT></TD>
</TR>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">24.1</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Power of Attorney (included in the signature page of this
Registration Statement).</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P>
<HR size="1" width="18%" align="left" noshade>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR valign="top">
      <TD width="1%" align="left" nowrap><FONT size="2">*</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="96%"><FONT size="2">Incorporated by reference in Post-Effective Amendment No.&nbsp;1 to the
Company&#146;s Registration Statement on Form&nbsp;10 (No.&nbsp;001-31257)</FONT></TD>
</TR>
<TR><TD><TR><TD><TR><TD><TR><TD>
<TR valign="top">
      <TD width="1%" align="left" nowrap><FONT size="2">**</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="96%"><FONT size="2">Incorporated by reference in Amendment No.&nbsp;2 to the Company&#146;s
Registration Statement on Form&nbsp;10 (No.&nbsp;001-31257).</FONT></TD>
</TR>
</TABLE>

<P align="center"><FONT size="2">9</FONT>

</BODY>
</HTML>
[{"type": "S-8", "sequence": "1", "filename": "a82548sv8.htm", "description": "FORM S-8", "secsgml_size_bytes": 52095}]
{"company-data": {"conformed-name": "ADVANCED MEDICAL OPTICS INC", "cik": "0001168335", "assigned-sic": "5040", "irs-number": "33098682", "state-of-incorporation": "DE"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-90950", "film-number": "02684429"}, "business-address": {"street1": "2525 DUPONT DR.", "city": "IRVINE", "state": "CA", "zip": "92612", "phone": "7142464500"}}
Advanced Medical Optics Inc  Form S-8
Table of Contents
As filed with the Securities and Exchange Commission on June 21, 2002
Registration No. 333-____
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
ADVANCED MEDICAL OPTICS, INC.
(Exact name of Registrant as specified in its charter)
Delaware
(State or other jurisdiction
of incorporation or organization)
33-098682
(I.R.S. Employer
Identification No.)
2525 Dupont Drive
Irvine, California 92612
(714) 246-4500
(Address of principal executive offices, including zip code, and telephone number)
ADVANCED MEDICAL OPTICS, INC. 401(K) PLAN
ADVANCED MEDICAL OPTICS, INC. 2002 INCENTIVE COMPENSATION PLAN
ADVANCED MEDICAL OPTICS, INC. 2002 EMPLOYEE STOCK PURCHASE PLAN
ADVANCED MEDICAL OPTICS, INC. 2002 INTERNATIONAL STOCK PURCHASE PLAN
ADVANCED MEDICAL OPTICS, INC. EXECUTIVE DEFERRED COMPENSATION PLAN
AMO IRISH SAVINGS RELATED SHARE OPTION SCHEME
AMO (IRELAND) SHARE PARTICIPATION SCHEME
(Full title of the plans)
JAMES V. MAZZO
Copies to:
President and
Chief Executive Officer
Advanced Medical Optics, Inc.
2525 Dupont Drive
Irvine, California 92612
(714) 246-4500
(Name, address, including zip code, and telephone number,
including area code, of agent for service)
CARY K. HYDEN
JONN R. BEESON
Latham & Watkins
650 Town Center, 20th floor
Costa Mesa, California 92626
(714) 540-1235
CALCULATION OF REGISTRATION FEE
Amount
Proposed Maximum
Proposed Maximum
Amount of
Title of Securities
to be
Offering Price
Aggregate Offering
Registration
to be Registered
Registered
Per Share
Price
Fee
Common Stock, par value $0.01 per share
10,300,000
(1)(2)
$
11.45
(3)
$
117,935,000
(3)
$
10,851
Deferred Compensation Obligations
$
3,000,000
(4)
100
%
$
3,000,000
$
276
(1)
Pursuant to Rule 416(a) under the Securities Act of 1933, as amended,
this Registration Statement shall also automatically cover any
additional shares of common stock, par value $0.01 per share (the
"Common Stock"), that become issuable under the plans being registered
pursuant to this Registration Statement by reason of any stock dividend,
stock split or other similar transaction.
(2)
Represents 400,000 shares authorized for issuance under the Advanced
Medical Optics, Inc. 401(k) Plan, 6,700,000 shares authorized for
issuance under the Advanced Medical Optics, Inc. 2002 Incentive
Compensation Plan, 2,900,000 shares authorized for issuance under the
Advance Medical Optics, Inc. 2002 Employee Stock Purchase Plan and 2002
International Stock Purchase Plan, 150,000 shares reserved for issuance under the AMO Irish Savings Related Share Option Scheme and
150,000 shares reserved for issuance under the AMO (Ireland) Share
Participation Scheme. In addition, pursuant to Rule 416(c) under the
Securities Act of 1933, as amended, this Registration Statement also
covers an indeterminate amount of interests to be offered or sold
pursuant to the Advanced Medical Optics, Inc. 401(k) Plan described
herein.
(3)
Estimated solely for the purpose of calculating the registration fee
pursuant to Rule 457(h) under the Securities Act of 1933, as amended,
and is based on the average of the high and low sales price of the
Company's Common Stock on June 20, 2002, trading on a "when issued"
basis.
1
Table of Contents
(4)
This Registration Statement is also filed for up to $3,000,000 in
deferred compensation obligations of the Company pursuant to the
Advanced Medical Optics, Inc. Executive Deferred Compensation Plan,
reflecting unsecured obligations of the Company to pay, in the future,
deferred compensation in accordance with the terms of such plan.
Proposed sale to take place from time to time after the effective date of the Registration Statement.
Total Pages 241
Exhibit Index on Page 9
2
TABLE OF CONTENTS
PART I
PART II
Item 3. Incorporation of Documents by Reference.
Item 4. Description of Securities.
Item 5. Interests of Named Experts and Counsel.
Item 6. Indemnification of Directors and Officers.
Item 7. Exemption from Registration Claimed.
Item 8. Exhibits.
Item 9. Undertakings.
SIGNATURES
EXHIBIT INDEX
EXHIBIT 5.1
EXHIBIT 10.1
EXHIBIT 10.2
EXHIBIT 10.3
EXHIBIT 10.4
EXHIBIT 10.5
Exhibit 23.1
Table of Contents
PART I
The information called for in Part I of Form S-8 is not being prepared
with or included in this Form S-8 (by incorporation by reference or otherwise)
in accordance with the rules and regulations of the Securities and Exchange
Commission ("SEC").
PART II
Item 3. Incorporation of Documents by Reference.
The following documents previously filed with the SEC by us are hereby
incorporated by reference in this Registration Statement:
(a)
Form 10 filed with the SEC on March 1, 2002, pursuant to the
Securities Exchange Act of 1934, as amended (the "Exchange Act"),
including any subsequent amendment or report filed for the purpose
of amending such description, which Form 10 includes the description
of our Common Stock.
All documents filed by us pursuant to Section 13(a), 13(c), 14 and 15(d)
of the Exchange Act subsequent to the date this Registration Statement is filed
with the SEC and prior to the filing of a post-effective amendment that
indicates that all securities offered have been sold or that deregisters all
securities then remaining unsold shall be deemed to be incorporated by
reference in this Registration Statement and to be a part of it from the
respective dates of filing of such documents. Any statement contained in a
document incorporated or deemed to be incorporated by reference herein shall be
deemed to be modified or superseded for purposes of this Registration Statement
to the extent that a statement contained herein or in any other subsequently
filed document that also is or is deemed to be incorporated by reference herein
modifies or supersedes such statement. Any such statement so modified or
superseded shall not be deemed, except as so modified or superseded, to
constitute a part of this Registration Statement.
Item 4. Description of Securities.
The following description of the deferred compensation obligations (the
"Obligations") of the Company under the Advanced Medical Optics, Inc. Executive
Deferred Compensation Plan (the "EDCP") is qualified by reference to the EDCP.
Capitalized terms used in this Item 4 and not otherwise defined in this
Registration Statement shall have the respective meanings attributed to such
terms in the EDCP.
The $3,000,000 of Obligations being registered under this Registration
Statement are to be offered to a select group of management and highly
compensated employees of the Company who meet certain eligibility requirements
and who have completed and submitted to the Company a written agreement
electing to participate in the EDCP (a "Participation Agreement"). The
Obligations are general unsecured and unfunded obligations of the Company to
pay deferred compensation in the future in accordance with the terms of the
EDCP.
The amount of compensation deferred by each participant in the EDCP is
determined in accordance with the EDCP based upon elections by each
participant. To participate in the EDCP, during the calendar year, a
participant must defer a minimum of $5,000 (or other such minimum amount as may
be designated by the committee that administers the EDCP (the "Committee"))
from either base salary or bonuses or a combination of base salary and bonuses,
and may elect to defer up to a maximum of 100% of such participant's base
salary and bonuses earned during the calendar year ("Deferral Amount") by
completing and submitting to the Company a "Deferral Election Form."
Obligations will consist of an amount equal to each participant's
"Deferral Account" under the EDCP, which includes (i) the sum of the
participant's Deferral Amounts, plus (ii) amounts credited to the participant's
Deferral Account based on the participant's selection from measurement fund
alternatives in accordance with and subject to the rules and procedures
established from time to time by the Committee, plus (iii) any Profit Sharing
Restoration Credits which have been added to the participant's Deferral
Account; plus (iv) any Matching Contribution Restoration Credits which have
been added to the participant's Deferral Account; plus (v) any Discretionary
Credits (amounts determined in the discretion of the Committee, not to exceed
$200,000 for any participant in any Plan Year) which have been added to the
participant's Deferral Account; less (vi) all distributions made to the
participant or his or her beneficiary pursuant to the EDCP that relate to the
participant's Deferral Account. For these purposes, (i) Profit Sharing
Restoration Credits equal the excess of the participant's "Profit Sharing
Contribution" (as defined in the Advanced Medical Optics, Inc. 401(k) Plan) for
the Plan Year under the
3
Table of Contents
Advanced Medical Optics, Inc. 401(k) Plan, had the participant's
"Compensation" (as defined in the Advanced Medical Optics, Inc. 401(k) Plan)
been calculated without deducting annual deferrals under the EDCP and had such
Profit Sharing Contribution been calculated without regard to Internal Revenue
Code limitations, over the participant's actual Profit Sharing Contribution for
the Plan Year under the Advanced Medical Optics, Inc. 401(k) Plan and (ii)
Matching Contribution Restoration Credits equal the excess of the participant's
"Matching Contributions" (as defined in the Advanced Medical Optics, Inc.
401(k) Plan) for the Plan Year under the Advanced Medical Optics, Inc. 401(k)
Plan, determined based on the participant's "Matched
Deposits" (as defined in the Advanced Medical Optics, Inc.
401(k) Plan) and had the participant's "Compensation" (as defined in the Advanced Medical
Optics, Inc. 401(k) Plan) been calculated without deducting annual deferrals
under the EDCP and had such Matching Contributions been calculated without
regard to Internal Revenue Code limitations, over the participant's actual
Matching Contributions for the Plan Year under the Advanced Medical Optics,
Inc. 401(k) Plan. A Matching Contribution Restoration Credit will be
credited to a participant's Deferral Account only if he or she
has contributed the maximum "Before Tax Deposits" (as
defined in the Advanced Medical Optics, Inc. 401(k) Plan) permitted
under the terms of the Advanced Medical Optics, Inc. 401(k) Plan for
a Plan Year.
A participant may elect in his or her Participation Agreement to receive
distributions from his or her Deferral Account in one of several manners,
including lump sum or installment payments. The distribution choices provided
to a participant may differ depending on the circumstances under which that
participant terminates employment with the Company, for instance by retirement,
death or disability. The participant also may be eligible to receive
distributions or make unscheduled withdrawals from his or her Deferral Account
while still employed with the Company.
An irrevocable rabbi trust established contemporaneously with the
establishment of the EDCP is to pay the Obligations. All amounts of base salary
or bonuses that are deferred under the EDCP shall be contributed to the trust.
The EDCP is administered by the Committee, which is appointed by the Corporate
Benefits Committee of the Company, and which has the power to make, amend,
interpret and enforce all appropriate rules and regulations for the
administration of the EDCP, to construe and resolve all questions arising under
the EDCP, and otherwise to carry out the terms of the EDCP. The Company, by
action of the Board, may terminate the EDCP at any time and may amend the EDCP
from time to time; provided, however, that no such amendment or termination
shall be effective, without the participant's consent, to the extent it reduces
or eliminates (except to the extent that amounts are distributed under the
EDCP) the value of a participant's Deferral Account balance in existence as of
such amendment or termination.
Item 5. Interests of Named Experts and Counsel.
The combined balance sheets of the optical medical device business of
Allergan, Inc. (Advanced Medical Optics, Inc.) as of December 31, 2001 and
2000, and the related combined statements of earnings, equity and comprehensive
income, and cash flows for each of the years in the three-year period ended
December 31, 2001, and the financial statement schedule contained in the Form
10, as amended, of Advanced Medical Optics, Inc. have been incorporated by
reference herein in reliance upon the report of KPMG LLP, independent certified
public accountants, incorporated by reference herein, and upon the authority of
said firm as experts in accounting and auditing.
Item 6. Indemnification of Directors and Officers.
The Company is incorporated under the laws of the State of Delaware.
Reference is made to Section 102(b)(7) of the Delaware General Corporation Law,
or DGCL, which enables a corporation in its original certificate of
incorporation or an amendment thereto to eliminate or limit the personal
liability of a director for violations of the director's fiduciary duty, except
(1) for any breach of the director's duty of loyalty to the corporation or its
stockholders, (2) for acts or omissions not in good faith or which involve
intentional misconduct or a knowing violation of law, (3) pursuant to Section
174 of the DGCL, which provides for liability of directors for unlawful
payments of dividends of unlawful stock purchase or redemptions, or (4) for any
transaction from which a director derived an improper personal benefit.
Reference is also made to Section 145 of the DGCL, which provides that a
corporation may indemnify any person, including an officer or director, who is,
or is threatened to be made, party to any threatened, pending or completed
legal action, suit or proceeding, whether civil, criminal, administrative or
investigative, other than an action by or in the right of such corporation, by
reason of the fact that such person was an officer, director, employee or agent
of such corporation or is or was serving at the request of such corporation as
a director, officer, employee or agent of another corporation or enterprise.
The indemnity may include expenses (including attorneys' fees), judgments,
fines and amounts paid in settlement actually and reasonably incurred by such
person in connection with such action, suit or proceeding, provided such
officer, director, employee or agent acted in good faith and in a manner he
reasonably believed to be in, or not opposed to, the corporation's best
interest and, for criminal proceedings, had no reasonable cause to believe that
his conduct was unlawful. A Delaware corporation may
4
Table of Contents
indemnify any officer or director in an action by or in the right of the
corporation under the same conditions, except that no indemnification is
permitted without judicial approval if the officer or director is adjudged to
be liable to the corporation. Where an officer or director is successful on
the merits or otherwise in the defense of any action referred to above, the
corporation must indemnify him against the expenses that such officer or
director actually and reasonably incurred.
Our amended and restated certificate of incorporation provides for
indemnification of the officers and directors to the full extent permitted by
applicable law.
Item 7. Exemption from Registration Claimed.
Not Applicable.
Item 8. Exhibits.
A list of exhibits filed with this Registration Statement is set forth in
the Exhibit Index and is incorporated herein by reference.
Item 9. Undertakings.
(a)  The undersigned registrant hereby undertakes:
(1)  To file, during any period in which offers or sales are being made, a
post-effective amendment to this Registration Statement:
(i)
To include any prospectus required by Section
10(a)(3) of the Securities Act of 1933
(the "Securities Act");
(ii)
To reflect in the prospectus any facts or events
arising after the effective date of this Registration
Statement (or the most recent post-effective amendment
thereof) which, individually or in the aggregate, represent a
fundamental change in the information set forth in this
Registration Statement. Notwithstanding the foregoing, any
increase or decrease in volume of securities offered (if the
total dollar value of securities offered would not exceed that
which was registered) and any deviation from the low or high
end of the estimated maximum offering range may be reflected
in the form of prospectus filed with the SEC pursuant to Rule
424(b) if, in the aggregate, the changes in volume and price
represent no more than 20 percent change in the maximum
aggregate offering price set forth in the "Calculation of
Registration Fee" table in the effective Registration
Statement; and
(iii)
To include any material information with respect
to the plan of distribution not previously disclosed in this
Registration Statement or any material change to such
information in this Registration Statement;
provided, however
, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the
information required to be included in a post-effective amendment by those
paragraphs is contained in periodic reports filed with or furnished to the SEC
by the Company pursuant to Section 13 or Section 15(d) of the Exchange Act that
are incorporated by reference in this Registration Statement.
(2)  That, for the purpose of determining any liability under the
Securities Act, each such post-effective amendment shall be deemed to be a new
Registration Statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial
bona
fide
offering thereof.
(3)  To remove from registration by means of a post-effective amendment any
of the securities being registered which remain unsold at the termination of
the offering.
(b)  The undersigned registrant hereby undertakes that, for purposes of
determining any liability under the Securities Act, each filing of an annual
report of the Company pursuant to Section 13(a) or Section 15(d) of the
Exchange Act (and, where applicable, each filing of an employee benefit plan's
annual report pursuant to Section 15(d) of the Exchange Act) that is
incorporated by reference in this Registration Statement shall be deemed to be
a
5
Table of Contents
new Registration Statement relating to the securities offered therein, and
the offering of such securities at that time shall be deemed to be the initial
bona fide
offering thereof.
(c)  Insofar as indemnification for liabilities arising under the
Securities Act may be permitted to directors, officers and controlling persons
of the Company pursuant to existing provisions, or otherwise, the Company has
been advised that in the opinion of the SEC such indemnification is against
public policy as expressed in the Securities Act and is, therefore,
unenforceable. In the event that a claim for indemnification against such
liabilities (other than the payment by the Company of expenses incurred or
paid by a director, officer or controlling person of the Company in the
successful defense of any action, suit or proceeding) is asserted by such
director, officer or controlling person in connection with the securities being
registered, the Company will, unless in the opinion of its counsel the matter
has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against public
policy as expressed in the Securities Act and will be governed by the final
adjudication of such issue.
6
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act, the Company certifies
that it has reasonable grounds to believe that it meets all of the requirements
for filing on Form S-8 and has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly authorized, in the High
Wycombe, England, on June 19, 2002.
ADVANCED MEDICAL OPTICS, INC.
By:
/s/ JAMES V. MAZZO
James V. Mazzo
President and Chief Executive Officer
POWER OF ATTORNEY
Pursuant to the requirements of the Securities Act, this Registration
Statement has been signed by the following persons in the capacities on June
19, 2002. Each person whose signature appears below authorizes James V. Mazzo
and Aimee S. Weisner, and either of them, with full power of substitution and
resubstitution, his true and lawful attorneys-in-fact, for him in any and all
capacities, to sign any amendments (including post-effective amendments or
supplements) to this Registration Statement and to file the same, with exhibits
thereto, and other documents in connection therewith, with the SEC.
Signature
Title
/s/ JAMES V. MAZZO
President and Chief Executive Officer (Principal
Executive Officer)
James V. Mazzo
/s/ WILLIAM R. GRANT
Chairman of the Board
William R. Grant
/s/ DAVID E.I. PYOTT
Director
David E. I. Pyott
/s/ RICHARD A. MEIER
Corporate Vice President and Chief Financial Officer
Richard A. Meier
/s/ ROBERT F. GALLAGHER
Vice President and Controller
Robert F. Gallagher
7
Table of Contents
SIGNATURE
The Plan
. Pursuant to the requirements of the Securities Act, the
Advanced Medical Optics, Inc. 401(k) Plan has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Irvine, State of California, on June 20, 2002.
ADVANCED MEDICAL OPTICS, INC. 401(K) PLAN
By:
Advanced Medical Optics, Inc.
Corporate Benefits Committee
Plan Administrator
/s/ RICHARD A. MEIER
Richard A. Meier
/s/ AIMEE S. WEISNER
Aimee S. Weisner
/s/ C. RUSSELL TRENARY III
C. Russell Trenary III
8
Table of Contents
EXHIBIT INDEX
EXHIBIT
PAGE
4.1
Specimen Common Stock certificates
*
4.2
Form of Rights Agreements and attached Form of Right Certificate and attached
Form of Certificate of Designations of Series A Participating Cumulative
Preferred Stock.
**
5.1
Opinion of Latham & Watkins
10.1
Advanced Medical Optics, Inc. 401(k) Plan
10.2
Advanced Medical Optics, Inc. 2002 Incentive Compensation Plan
10.3
Advanced Medical Optics, Inc. 2002 Employee Stock Purchase Plan
10.4
Advanced Medical Optics, Inc. International Stock Purchase Plan
10.5
Advanced Medical Optics, Inc. Executive Deferred Compensation Plan
23.1
Consent of KPMG LLP, Independent Auditors.
23.2
Consent of Latham & Watkins (included in Exhibit 5.1).
24.1
Power of Attorney (included in the signature page of this
Registration Statement).
*
Incorporated by reference in Post-Effective Amendment No. 1 to the
Company's Registration Statement on Form 10 (No. 001-31257)
**
Incorporated by reference in Amendment No. 2 to the Company's
Registration Statement on Form 10 (No. 001-31257).
9